OSSOPAN cpr pell 830 mg 40 pce

7680453860159 CH-45386 A12CX
OSSOPAN cpr pell 830 mg 40 pce
OSSOPAN cpr pell 830 mg 40 pce
OSSOPAN cpr pell 830 mg 40 pce
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Articles (1)

Ossopan 800, Filmtabletten
Filmtabletten
40
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/02/2024
Patient information leaflet
Français
13/02/2024
Patient information leaflet
Italien
13/02/2024
Professional SmPC
Allemand
13/02/2024
Professional SmPC
Français
13/02/2024

Detailed composition

Substance Quantity Type Category
osseinum-hydroxyapatit
830.0 MG Substance WIZUS
collagena
216.0 MG Substance Wirkstoff (Principe actif)
peptida
75.0 MG Substance Wirkstoff (Principe actif)
calcium
178.0 MG Substance Wirkstoff (Principe actif)
phosphorus ruber
82.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
solani amylum
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 6000
- Substance HNIDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK

Authorization holder

Pierre Fabre Pharma SA

4052 Basel

Authorization information

Swissmedic authorization number
45386
Drug name
Ossopan 800, Filmtabletten
Galenic form
FILM
ATC Code
A12CX
Authorization status
Revoked/Withdrawn
Dispensation category
D
First authorization
12/12/1986
Authorization expiration date
21/04/2026
IT number
07.02.2.
Domain
Human medicine
Field of application
Osteoporose

Packaging details

Description (FR)
OSSOPAN cpr pell 830 mg 40 pce
Description (DE)
OSSOPAN Filmtabl 830 mg 40 Stk
Market launch
12/12/1986
Market withdrawal
21/04/2026
Narcotic (BTM)
No

Other packaging sizes

OSSOPAN cpr pell 830 mg 120 pce
120 TABL
View
Buy us a coffee Explore the data